Adam Goulburn, a partner at Lux Capital, was first struck by Eikon Therapeutics’ pitch to use super microscopes to develop drugs when founder Eric Betzig posed a simple question: How can you understand life if you don’t look at it live? “It was such a simple statement, but it was kind of eye opening to […]
© 2024 TechCrunch. All rights reserved. For personal use only.